SCHEMBL7258342

SCHEMBL7258342

CC(=O)OCC12CN(S(=O)(=O)c3ccc(Br)cc3)CC(=O)N1CC1(CCN(Cc3ccccc3)CC1)O2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
CYP2D6 P10635 3/20 0.39
CYP3A4 P08684 2/20 0.39
USP2 O75604 2/20 0.39
CYP1A2 P05177 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
OPRM1 P35372 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MMP1 P03956 2/20 0.37
MMP9 P14780 2/20 0.37
MMP13 P45452 2/20 0.37
ADAM17 P78536 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257489 0.90 LMNA (0.43) TSHRLMNAHTTCYP2D6CYP3A4
SCHEMBL7258008 0.88 TSHR (0.44) TSHRLMNAHTTCYP2D6CYP3A4
SCHEMBL6078643 0.87 F10 (0.41) TSHRLMNAHTTALDH1A1MEN1
SCHEMBL6079058 0.80 MGLL (0.42) TSHRCYP2D6CYP3A4USP2ALDH1A1
SCHEMBL6078359 0.78 ALDH1A1 (0.42) TSHRLMNACYP2D6CYP3A4USP2
SCHEMBL6854877 0.77 ALDH1A1 (0.42) TSHRLMNAHTTCYP2D6CYP3A4
SCHEMBL7261993 0.76 TGM2 (0.42) MEN1KMT2AMMP1MMP9
SCHEMBL6079034 0.76 F10 (0.41) TSHRLMNAHTTCYP2D6CYP3A4
SCHEMBL7261681 0.75 TGM2 (0.45) TSHRMEN1KMT2ACYP2C19SMN1; SMN2
SCHEMBL6079274 0.75 F10 (0.47) TSHRLMNACYP2D6USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346994-A1 CHOLESTEROL BIOSYNTHESIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT TRICYCLIC SPIRO COMPOUNDS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed